Mibeserc 16mg (3 blisters x 20 tablets/box)

Indications

Treatment of Ménière’s syndrome, symptoms of which may include vertigo, tinnitus, hearing loss and nausea.

Contraindications

Hypersensitivity to betahistine or to any of the excipients. Patients with phaeochromocytoma.

Compositon/Ingredients

Dosage and administration

Adults: Initial oral treatment is 8 to 16 mg three times daily, taken preferably with meals. Maintenance doses are generally in the range 24 – 48 mg daily. Daily dose should not exceed 48 mg.

Precaution

Caution is advised in patients with a history of peptic ulcer; patients with bronchial asthma; patients with urticaria, rashes or allergic rhinitis; patients with severe hypotension. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose – galactose malabsorption should not use Betahistine should not be used during pregnancy unless clearly necessary. The importance of the drug to the mother should be weighed against the benefits of nursing and the potential risks for the child.

Storage

Store at temperature below 30°C, protect from light.